We chose 7 months of cobinamide treatment because 3 months of treatment showed a trend toward reduced aortic dilation that did not reach significance.
← all excerpts
The Antioxidant/Nitric Oxide-Quenching Agent Cobinamide Prevents Aortic Disease in a Mouse Model of Marfan Syndrome.
1
—
—